Inflammatory mediator production in swine following endotoxin challenge with or without co-administration of dexamethasoneMYERS, Michael J; FARRELL, Dorothy E; PALMER, Douglas C et al.International immunopharmacology. 2003, Vol 3, Num 4, pp 571-579, issn 1567-5769, 9 p.Article

Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T CellsWRZESINSKI, Claudia; PAULOS, Chrystal M; KAISER, Andrew et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 1-7, issn 1524-9557, 7 p.Article

Determinants of Successful CD8⁺ T-Cell Adoptive Immunotherapy for Large Established Tumors in MiceKLEBANOFF, Christopher A; GATTINONI, Luca; ROSENBERG, Steven A et al.Clinical cancer research (Print). 2011, Vol 17, Num 16, pp 5343-5352, issn 1078-0432, 10 p.Article

Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. CommentaryZECHER, Daniel; LAKKIS, Fadi G; CLAVIEN, Pierre-Alain et al.Blood. 2008, Vol 111, Num 9, issn 0006-4971, 4426-4427, 4588-4595 [10 p.]Article

CTLA-4 dysregulation of self/tumor-reactive CD8⁺ T-cell function is CD4⁺ T-cell dependentGATTINONI, Luca; RANGANATHAN, Anju; SURMAN, Deborah R et al.Blood. 2006, Vol 108, Num 12, pp 3818-3823, issn 0006-4971, 6 p.Article

Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic MelanomaYEH, Steven; KARNE, Need K; YANG, James C et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 5, pp 981-989, issn 0161-6420, 9 p.Article

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. CommentaryDARCY, Phillip K; HINRICHS, Christian S; RESTIFO, Nicholas P et al.Blood. 2008, Vol 111, Num 11, issn 0006-4971, 5268-5269, 5326-5333 [10 p.]Article

Tumor-specific Th17-polarized cells eradicate large established melanoma. CommentaryBRONTE, Vincenzo; MURANSKI, Pawel; PTAK, Krzysztof et al.Blood. 2008, Vol 112, Num 2, issn 0006-4971, 214, 362-373 [13 p.]Article

Tumor-Specific CD8⁺ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted HostsKERKAR, Sid P; MURANSKI, Pawel; MORGAN, Richard A et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 17, pp 6725-6734, issn 0008-5472, 10 p.Article

The in vivo expansion rate of properly stimulated transferred CD8⁺ T cells exceeds that of an aggressively growing mouse tumorHWANG, Leroy N; ZHIYA YU; PALMER, Douglas C et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 1132-1138, issn 0008-5472, 7 p.Article

Glucocorticoids do not inhibit antitumor activity of activated CDB⁺ T CellsHINRICHS, Christian S; PALMER, Douglas C; ROSENBERG, Steven A et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 6, pp 517-524, issn 1524-9557, 8 p.Article

Human effector CD8⁺ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyHINRICHS, Christian S; BORMAN, Zachary A; MURANSKI, Pawel et al.Blood. 2011, Vol 117, Num 3, pp 808-814, issn 0006-4971, 7 p.Article

Programming tumor-reactive effector memory CD8⁺ T cells in vitro obviates the requirement for in vivo vaccinationKLEBANOFF, ChristopherA; ZHIYA YU; HWANG, Leroy N et al.Blood. 2009, Vol 114, Num 9, pp 1776-1783, issn 0006-4971, 8 p.Article

Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriersBONI, Andrea; MURANSKI, Pawel; RESTIFO, Nicholas P et al.Blood. 2008, Vol 112, Num 12, pp 4746-4754, issn 0006-4971, 9 p.Article

Toll-like receptors in tumor immunotherapyPAULOS, Chrystal M; KAISER, Andrew; ANTONY, Paul A et al.Clinical cancer research. 2007, Vol 13, Num 18, pp 5280-5289, issn 1078-0432, 10 p., 1Article